Guidance Point Advisors’s Gilead Sciences GILD Stock Holding History

Guidance Point Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10	Closed	–	–	202
2021 Q3	$0	Buy	+10	New	+$703	﹤0.01%	422

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guidance Point Advisors's GILD Position: Q4 2021 in Review

Guidance Point Advisors sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 10 shares.

Guidance Point Advisors first reported a position in GILD in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Guidance Point Advisors reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
Guidance Point Advisors sold 10 Gilead Sciences shares in Q4 2021.
Guidance Point Advisors first reported a position in Gilead Sciences in Q3 2021 and held it in 1 quarter.
Guidance Point Advisors's Gilead Sciences position peaked at $0 in Q3 2021.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Guidance Point Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.